Evidence map›Paper›PMID 39479752›Full record

ArticlePigment cell & melanoma research2025

The Lipid Droplet Protein DHRS3 Is a Regulator of Melanoma Cell State.

Eleanor Johns, Yilun Ma, Pakavarin Louphrasitthiphol, Christopher Peralta, Miranda V Hunter, Jeremy H Raymond, Henrik Molina, Colin R Goding, Richard M White

Abstract read
In one paragraph

Article in Pigment cell & melanoma research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Tissue-Specific Expression of the PorcineAnimals : an open access journal from MDPI · 2025
    Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Eleanor JohnsCancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID 0000-0001-6802-041X
Yilun MaCancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Pakavarin LouphrasitthipholLudwig Institute for Cancer Research, University of Oxford, Oxford, UK.ORCID 0000-0001-6546-332X
Christopher PeraltaThe Proteomics Resource Center at the Rockefeller University, New York, New York, USA.
Miranda V HunterCancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID 0000-0002-6971-1738
Jeremy H RaymondLudwig Institute for Cancer Research, University of Oxford, Oxford, UK.ORCID 0000-0002-8712-895X
Henrik MolinaThe Proteomics Resource Center at the Rockefeller University, New York, New York, USA.
Colin R GodingLudwig Institute for Cancer Research, University of Oxford, Oxford, UK.ORCID 0000-0002-1614-3909
Richard M WhiteCancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID 0000-0001-9099-9169

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
Weill Cornell/Rockefeller/Sloan Kettering MST ProgramT32GM152349 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI KATHARINE C HSU · 2024 to 2026
$6.6M
Dissecting the complexity of metastasis with mathematical models and quantitative experiments with in zebrafishR01CA229215 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI WHITE, RICHARD MARK, XAVIER, JOAO · 2018 to 2022
$3.1M
Identification and characterization of cancer cell states by novel computational and experimental technologies - Resubmission - 1U01CA260432 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Richard Mark White, ITAI YANAI · 2022 to 2026
$2.9M
Evolutionary dynamics of melanoma metastasisDP2CA186572 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI WHITE, RICHARD MARK · 2013 to 2013
$2.7M
The integrated stress response and the microenvironment in melanoma progressionR01CA268597 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Colin Goding, Constantinos Koumenis · 2022 to 2026
$2.0M
Lipid programs in melanocyte transformationR01CA238317 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI OVERHOLTZER, MICHAEL H., WHITE, RICHARD MARK · 2020 to 2025
$2.0M
The role of the novel interface cell state in melanoma invasionK99CA266931 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI HUNTER, MIRANDA VICTORIA · 2023 to 2024
$346k
In vivo characterization of keratinocytes in the melanoma microenvironmentF30CA265124 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI MA, YILUN · 2021 to 2024
$206k
Investigating the role of fatty acid metabolism in melanocyte differentiation: Insights into the metabolic requirements of developmentF31AR079215 · NIAMS · SLOAN-KETTERING INST CAN RESEARCH · PI JOHNS, ELEANOR MAY · 2021 to 2024
$146k
Alan and Sandra Gerry Metastasis and Tumor Ecosystems CenterAmerican Cancer SocietyHarry J. Lloyd Charitable TrustLudwig Institute for Cancer ResearchMark Foundation For Cancer ResearchMelanoma Research AllianceNCI NIH HHS DP2 CA186572NCI NIH HHS F30 CA265124NCI NIH HHS K99 CA266931NCI NIH HHS K99CA266931NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA229215NCI NIH HHS R01 CA238317NCI NIH HHS R01 CA268597NCI NIH HHS U01 CA260432NIAMS NIH HHS F31 AR079215NIAMS NIH HHS F31AR079215NIGMS NIH HHS T32 GM007739NIGMS NIH HHS T32 GM152349NIH HHS P30 CA008748NIH HHS R01CA229215NIH HHS R01CA238317NIH HHS R01 CA268597-01NIH HHS T32GM007739Pershing Square Foundation
6 · The paper itself

Abstract

Lipid droplets are fat storage organelles composed of a protein envelope and lipid-rich core. Regulation of this protein envelope underlies differential lipid droplet formation and function. In melanoma, lipid droplet formation has been linked to tumor progression and metastasis, but it is unknown whether lipid droplet proteins play a role. To address this, we performed proteomic analysis of the lipid droplet envelope in melanoma. We found that lipid droplet proteins were differentially enriched in distinct melanoma states; from melanocytic to undifferentiated. DHRS3, which converts all-trans-retinal to all-trans-retinol, is upregulated in the MITF

Indexed as

Gene Expression Regulation, NeoplasticMelanomaCell DifferentiationCell Line, TumorHumansLipid DropletsMelanocytesMicrophthalmia-Associated Transcription FactorNeoplasm InvasivenessProteomicsSignal TransductionTretinoinMicrophthalmia-Associated Transcription FactorTretinoincell stateDHRS3lipid dropletmelanomaretinoic acid

Identifiers

PMID39479752
PMCPMC12244328

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.